Synthetic THC And Blood Pressure

Overview

About this study

To investigate the effects of Dronabinol use on blood pressure and neurovascular physiology

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Recreational occasional Cannabis use (Consuming THC less than 2 times a week)

  • 21 – 40 years of age

  • Biological male or female

Exclusion Criteria:

  • BMI > 35 kg/m2

  • Diagnosed psychiatric disorders

  • Hypotension

  • History of seizures

  • History of substance abuse or recreational drug use or positive urine drug screen.

  • History of uncontrolled disease including:

    • Cardiovascular

    • Pulmonary

    • Gastrointestinal

    • Pancreatic

    • Hepatic

    • Renal

    • Hematological

    • Endocrine (including Type I Diabetes)

    • Neurological

    • Urological

    • Sleep disorders

  • Pregnant or breastfeeding

  • Use of certain antimicrobial, chemotherapeutic, anticoagulant, hypoglycemic, anti-inflammatory, psychotropic, and antihistamine drugs.

  • Prescribed CYP2C9 and/or CYP3A4 inhibitors.

  • History of shift work or rotating shifts within 1 month.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 7/30/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Virend Somers

Open for enrollment

Contact information:

Preventive Heart Research Team

(507) 538-7425

rstcvruprevent@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20597253

Mayo Clinic Footer